Validus Pharms Drug Patent Portfolio
Validus Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Validus Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6977253 | Methods for the treatment of bipolar disorder using carbamazepine | 19 May, 2024 | Expired |
| US5912013 | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine | 15 Jun, 2016 | Expired |
Latest Legal Activities on Validus Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Validus Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 23 Jul, 2010 | US6977253 (Litigated) |
|
Correspondence Address Change
Critical
| 22 Jul, 2010 | US6977253 (Litigated) |
| Mail Pre-Exam Notice | 25 Jun, 2010 | US6977253 (Litigated) |
|
Correspondence Address Change
Critical
| 24 Jun, 2010 | US6977253 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 28 Dec, 2007 | US6977253 (Litigated) |
|
Correspondence Address Change
Critical
| 03 Dec, 2007 | US6977253 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 20 Dec, 2005 | US6977253 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Dec, 2005 | US6977253 (Litigated) |
|
Issue Notification Mailed
Critical
| 30 Nov, 2005 | US6977253 (Litigated) |
| Dispatch to FDC | 18 Nov, 2005 | US6977253 (Litigated) |
|
Application Is Considered Ready for Issue
Critical
| 11 Nov, 2005 | US6977253 (Litigated) |
|
Issue Fee Payment Received
Critical
| 25 Oct, 2005 | US6977253 (Litigated) |
|
Issue Fee Payment Verified
Critical
| 25 Oct, 2005 | US6977253 (Litigated) |
|
Mail Notice of Allowance
Critical
| 19 Oct, 2005 | US6977253 (Litigated) |
| Mail Examiner's Amendment | 19 Oct, 2005 | US6977253 (Litigated) |
Validus Pharms's Family Patents
Validus Pharms drugs have patent protection in a total of 2 countries. It has a significant patent presence in the US with 75.0% of its patents being US patents. Click
below to unlock the full patent family tree.
Validus Pharms Drug List
Given below is the complete list of Validus Pharms's drugs and the patents protecting them.
1. Equetro
Equetro is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6977253 | Methods for the treatment of bipolar disorder using carbamazepine |
19 May, 2024
(4 months ago)
| Expired |
| US5912013 | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
15 Jun, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Equetro's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List